Jay MD - SIGA Technologies Chief VP

SIGA Stock  USD 6.27  0.02  0.32%   

VP

Jay MD is Chief VP of SIGA Technologies
Age 52
Address 31 East 62nd Street, New York, NY, United States, 10065
Phone212 672 9100
Webhttps://www.siga.com

SIGA Technologies Management Efficiency

The company has return on total asset (ROA) of 0.3695 % which means that it generated a profit of $0.3695 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5839 %, meaning that it created $0.5839 on every $100 dollars invested by stockholders. SIGA Technologies' management efficiency ratios could be used to measure how well SIGA Technologies manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.28. The current year's Return On Capital Employed is expected to grow to 0.44. At present, SIGA Technologies' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 23.1 M, whereas Non Currrent Assets Other are forecasted to decline to about 2 M.
SIGA Technologies currently holds 1.46 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. SIGA Technologies has a current ratio of 9.02, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about SIGA Technologies' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 12 records

VP Age

Gregory DavisAvadel Pharmaceuticals PLC
59
MPH MDIronwood Pharmaceuticals
N/A
Thomas CastellanoCatalent
44
Mona DesaiPhibro Animal Health
N/A
Shirley JDCollegium Pharmaceutical
40
Anthony CPAPhibro Animal Health
55
Michael HatzfeldCatalent
51
Thomas McHughAvadel Pharmaceuticals PLC
59
MBA MSIronwood Pharmaceuticals
N/A
Joseph JDCatalent
46
Judith WeinsteinPhibro Animal Health
55
David JDAlkermes Plc
52
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. The company was incorporated in 1995 and is headquartered in New York, New York. Siga Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs people. SIGA Technologies (SIGA) is traded on NASDAQ Exchange in USA. It is located in 31 East 62nd Street, New York, NY, United States, 10065 and employs 45 people. SIGA Technologies is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

SIGA Technologies Leadership Team

Elected by the shareholders, the SIGA Technologies' board of directors comprises two types of representatives: SIGA Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SIGA. The board's role is to monitor SIGA Technologies' management team and ensure that shareholders' interests are well served. SIGA Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SIGA Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jay MD, Chief VP
Tove Bolken, Senior Officer
Herb Vloedman, Senior Officer
III MD, CEO Director
JD Esq, General Counsel
Daniel CPA, CFO VP
Dennis Hruby, Chief Scientific Officer and VP
Daniel Luckshire, CFO, Principal Accounting Officer, Executive VP and Secretary
Diem MBA, CEO Director

SIGA Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SIGA Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether SIGA Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SIGA Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Siga Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Siga Technologies Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SIGA Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For information on how to trade SIGA Stock refer to our How to Trade SIGA Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SIGA Technologies. If investors know SIGA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SIGA Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.721
Earnings Share
1.17
Revenue Per Share
2.441
Quarterly Revenue Growth
0.084
Return On Assets
0.3695
The market value of SIGA Technologies is measured differently than its book value, which is the value of SIGA that is recorded on the company's balance sheet. Investors also form their own opinion of SIGA Technologies' value that differs from its market value or its book value, called intrinsic value, which is SIGA Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SIGA Technologies' market value can be influenced by many factors that don't directly affect SIGA Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SIGA Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if SIGA Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SIGA Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.